Clinical Trials Logo

Clinical Trial Summary

A pragmatic, comparative effectiveness trial of glyburide versus metformin.


Clinical Trial Description

Patients with gestational diabetes requiring pharmaceutical treatment will be randomized to receive glyburide or metformin. Dose increases will be determined by the patient's physician. Patients will be determined to have failed either medication if glucose control can not be achieved with the maximum dose of the medication, if insulin is stared to achieve glucose control or if another oral agent is started along for glucose control. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03078725
Study type Interventional
Source The University of Texas Health Science Center, Houston
Contact
Status Withdrawn
Phase Phase 4
Start date June 20, 2017
Completion date May 10, 2018

See also
  Status Clinical Trial Phase
Terminated NCT05647798 - Intrapartum Glycemic Control in GDMA2 N/A